Latest Breaking News On - Raquel conakcsa strategic communications - Page 1 : comparemela.com

Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Capricor Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San diegoUnited statesLinda marbLos angelesMichael kelliherNippon shinyaku co ltdInternational annual congressCo ltdExosome platform technologyJoyce allairelifesci advisorsRaquel conakcsa strategic communicationsExosome based therapeutic development summitDuchenne muscular dystrophy programBusiness development at horizon therapeuticsAmerican association of extracellular vesiclesNs pharma inc

Capricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14

Capricor Therapeutics to Present Third Quarter 2023 Financial Results and Recent Corporate Update on November 14
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesCapricor company contactExchange commission onNs pharma incRaquel conakcsa strategic communicationsNippon shinyaku co ltdCapricor therapeutics incJoyce allairelifesci advisorsTherapeutics third quarterRecent corporate update conference callCall detailsPrivate securities litigation reform actAnnual reportExchange commissionQuarterly reportInvestigational new drug

Capricor Therapeutics (CAPR) Announces 4 94M Share Offering at $4 66/sh

Capricor Therapeutics (CAPR) Announces 4 94M Share Offering at $4 66/sh
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesNew yorkNs pharma incExchange commissionCapricor company contactCapricor therapeutics incRaquel conakcsa strategic communicationsExchange commission onHighbridge capital managementCantor fitzgerald coNippon shinyaku co ltdHc wainwright coJoyce allairelifesci advisorsCo ltdCapricor therapeuticsNippon shinyaku

Capricor Therapeutics (CAPR) Appoints Paul Auwaerter to its Board

Capricor Therapeutics (CAPR) Appoints Paul Auwaerter to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLinda marbPaul auwaerterNs pharma incColumbia universityCapricor therapeutics incCapricor company contactDivision of infectious diseasesJoyce allairelifesci advisorsRaquel conakcsa strategic communicationsInformation technology centerJohns hopkins university school of medicineNippon shinyaku co ltdHealthcare solutionsExchange commission onKen fisher center

Capricor Therapeutics Announces Positive 24-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy

Capricor Therapeutics Announces Positive 24-Month Results from Ongoing HOPE-2 Open Label Extension Study of CAP-1002 in Duchenne Muscular Dystrophy
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesLinda marbRaquel conakcsa strategic communicationsNs pharma incExchange commission onNippon shinyaku co ltdJoyce allairelifesci advisorsCapricor company contactCapricor therapeutics incDrug administrationLeft ventricular ejection fractionPatients suggest preservationUpper limbShow long term benefitSkeletal muscle functionEfficacy results continue